This NDC is on FDA's drug shortage list (posted Jul 14, 2023)

Reported reason: Other

Product Information

LISDEXAMFETAMINE 40 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $2.6298 per EA under NDC 57664004988. Its NADAC has been published 150 times since Oct 11, 2023.

FDA first approved this application on Aug 25, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISDEXAMFETAMINE 40 MG CAPSULE

LISDEXAMFETAMINE DIMESYLATE
$2.6298per EA
DEA Schedule CII

Strength

40 mg/1

NDC

57664004988

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA214484

FDA Approved

8/25/2023

TE Code

AB

On Market Since

8/25/2023

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price Statistics

The NADAC for LISDEXAMFETAMINE 40 MG CAPSULE has been published 150 times since Oct 11, 2023, and over the history we have for it it has declined 21.1%. The table below summarizes its recorded NADAC range and movement.

Current price$2.6298 per EA
All-time high$6.5053 (Mar 13, 2024)
All-time low$2.6298 (Aug 19, 2026)
52-week high$3.7294
52-week low$2.6298
Median price$4.0492
Average price$4.0334
Largest weekly change+41.6% (Jan 17, 2024)
Weeks tracked150
Tracking sinceOct 11, 2023

Price History

1W

-3.5%

1M

-6.6%

3M

-10.0%

6M

-15.2%

1Y

-32.7%

3Y

N/A

5Y

N/A

All

-21.1%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LISDEXAMFETAMINE 40 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for LISDEXAMFETAMINE 40 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $2.6298 per EA (NDC 57664004988), effective Aug 19, 2026.

How has the price of LISDEXAMFETAMINE 40 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for LISDEXAMFETAMINE 40 MG CAPSULE has declined 21.1%. It has been tracked across 150 weekly CMS publications since Oct 11, 2023.

What are the highest and lowest recorded NADAC prices for LISDEXAMFETAMINE 40 MG CAPSULE?

Since Oct 11, 2023, the NADAC for LISDEXAMFETAMINE 40 MG CAPSULE has ranged from a low of $2.6298 (Aug 19, 2026) to a high of $6.5053 (Mar 13, 2024), with a median of $4.0492 per EA.

Are there cheaper alternatives to LISDEXAMFETAMINE 40 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISDEXAMFETAMINE 40 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures LISDEXAMFETAMINE 40 MG CAPSULE?

LISDEXAMFETAMINE 40 MG CAPSULE (NDC 57664004988) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.

Is LISDEXAMFETAMINE 40 MG CAPSULE in shortage?

Yes — NDC 57664004988 is currently listed in FDA's drug shortage database (posted Jul 14, 2023). Reported reason: Other.